- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Plasma Fractionation market will register a 7.1% CAGR in terms of revenue, the global market size will reach $ 33810 million by 2025, from $ 25740 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Plasma Fractionation business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation market by type, application, key manufacturers and key regions and countries.
This study considers the Plasma Fractionation value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Albumin
Immune Globulin
Coagulation Factor
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immunity
Therapy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxalta)
CBPO
CSL
Octapharma
Kedrion
Grifols
BPL
LFB Group
RAAS
Biotest
Hualan Bio
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Plasma Fractionation consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Plasma Fractionation market by identifying its various subsegments.
Focuses on the key global Plasma Fractionation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma Fractionation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Plasma Fractionation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma Fractionation Consumption 2015-2025
2.1.2 Plasma Fractionation Consumption CAGR by Region
2.2 Plasma Fractionation Segment by Type
2.2.1 Albumin
2.2.2 Immune Globulin
2.2.3 Coagulation Factor
2.2.4 Other
2.3 Plasma Fractionation Consumption by Type
2.3.1 Global Plasma Fractionation Consumption Market Share by Type (2015-2020)
2.3.2 Global Plasma Fractionation Revenue and Market Share by Type (2015-2020)
2.3.3 Global Plasma Fractionation Sale Price by Type (2015-2020)
2.4 Plasma Fractionation Segment by Application
2.4.1 Immunity
2.4.2 Therapy
2.4.3 Other
2.5 Plasma Fractionation Consumption by Application
2.5.1 Global Plasma Fractionation Consumption Market Share by Type (2015-2020)
2.5.2 Global Plasma Fractionation Value and Market Share by Type (2015-2020)
2.5.3 Global Plasma Fractionation Sale Price by Type (2015-2020)
3 Global Plasma Fractionation by Company
3.1 Global Plasma Fractionation Sales Market Share by Company
3.1.1 Global Plasma Fractionation Sales by Company (2018-2020)
3.1.2 Global Plasma Fractionation Sales Market Share by Company (2018-2020)
3.2 Global Plasma Fractionation Revenue Market Share by Company
3.2.1 Global Plasma Fractionation Revenue by Company (2018-2020)
3.2.2 Global Plasma Fractionation Revenue Market Share by Company (2018-2020)
3.3 Global Plasma Fractionation Sale Price by Company
3.4 Global Plasma Fractionation Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Plasma Fractionation Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Plasma Fractionation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Plasma Fractionation by Regions
4.1 Plasma Fractionation by Regions
4.2 Americas Plasma Fractionation Consumption Growth
4.3 APAC Plasma Fractionation Consumption Growth
4.4 Europe Plasma Fractionation Consumption Growth
4.5 Middle East & Africa Plasma Fractionation Consumption Growth
5 Americas
5.1 Americas Plasma Fractionation Consumption by Countries
5.1.1 Americas Plasma Fractionation Consumption by Countries (2015-2020)
5.1.2 Americas Plasma Fractionation Value by Countries (2015-2020)
5.2 Americas Plasma Fractionation Consumption by Type
5.3 Americas Plasma Fractionation Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Plasma Fractionation Consumption by Regions
6.1.1 APAC Plasma Fractionation Consumption by Regions (2015-2020)
6.1.2 APAC Plasma Fractionation Value by Regions (2015-2020)
6.2 APAC Plasma Fractionation Consumption by Type
6.3 APAC Plasma Fractionation Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Plasma Fractionation by Countries
7.1.1 Europe Plasma Fractionation Consumption by Countries (2015-2020)
7.1.2 Europe Plasma Fractionation Value by Countries (2015-2020)
7.2 Europe Plasma Fractionation Consumption by Type
7.3 Europe Plasma Fractionation Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Plasma Fractionation by Countries
8.1.1 Middle East & Africa Plasma Fractionation Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Plasma Fractionation Value by Countries (2015-2020)
8.2 Middle East & Africa Plasma Fractionation Consumption by Type
8.3 Middle East & Africa Plasma Fractionation Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Plasma Fractionation Distributors
10.3 Plasma Fractionation Customer
11 Global Plasma Fractionation Market Forecast
11.1 Global Plasma Fractionation Consumption Forecast (2021-2025)
11.2 Global Plasma Fractionation Forecast by Regions
11.2.1 Global Plasma Fractionation Forecast by Regions (2021-2025)
11.2.2 Global Plasma Fractionation Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Plasma Fractionation Forecast by Type
11.8 Global Plasma Fractionation Forecast by Application
12 Key Players Analysis
12.1 Shire (Baxalta)
12.1.1 Company Information
12.1.2 Plasma Fractionation Product Offered
12.1.3 Shire (Baxalta) Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Shire (Baxalta) Latest Developments
12.2 CBPO
12.2.1 Company Information
12.2.2 Plasma Fractionation Product Offered
12.2.3 CBPO Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CBPO Latest Developments
12.3 CSL
12.3.1 Company Information
12.3.2 Plasma Fractionation Product Offered
12.3.3 CSL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CSL Latest Developments
12.4 Octapharma
12.4.1 Company Information
12.4.2 Plasma Fractionation Product Offered
12.4.3 Octapharma Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Kedrion
12.5.1 Company Information
12.5.2 Plasma Fractionation Product Offered
12.5.3 Kedrion Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Kedrion Latest Developments
12.6 Grifols
12.6.1 Company Information
12.6.2 Plasma Fractionation Product Offered
12.6.3 Grifols Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Grifols Latest Developments
12.7 BPL
12.7.1 Company Information
12.7.2 Plasma Fractionation Product Offered
12.7.3 BPL Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 BPL Latest Developments
12.8 LFB Group
12.8.1 Company Information
12.8.2 Plasma Fractionation Product Offered
12.8.3 LFB Group Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 LFB Group Latest Developments
12.9 RAAS
12.9.1 Company Information
12.9.2 Plasma Fractionation Product Offered
12.9.3 RAAS Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 RAAS Latest Developments
12.10 Biotest
12.10.1 Company Information
12.10.2 Plasma Fractionation Product Offered
12.10.3 Biotest Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Biotest Latest Developments
12.11 Hualan Bio
12.11.1 Company Information
12.11.2 Plasma Fractionation Product Offered
12.11.3 Hualan Bio Plasma Fractionation Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Hualan Bio Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Plasma Fractionation Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players o
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
